JP2006511442A5 - - Google Patents

Download PDF

Info

Publication number
JP2006511442A5
JP2006511442A5 JP2004506350A JP2004506350A JP2006511442A5 JP 2006511442 A5 JP2006511442 A5 JP 2006511442A5 JP 2004506350 A JP2004506350 A JP 2004506350A JP 2004506350 A JP2004506350 A JP 2004506350A JP 2006511442 A5 JP2006511442 A5 JP 2006511442A5
Authority
JP
Japan
Prior art keywords
mouse
injection
epitope
effector
shows
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004506350A
Other languages
English (en)
Japanese (ja)
Other versions
JP4309837B2 (ja
JP2006511442A (ja
Filing date
Publication date
Priority claimed from FR0206111A external-priority patent/FR2839722A1/fr
Application filed filed Critical
Publication of JP2006511442A publication Critical patent/JP2006511442A/ja
Publication of JP2006511442A5 publication Critical patent/JP2006511442A5/ja
Application granted granted Critical
Publication of JP4309837B2 publication Critical patent/JP4309837B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004506350A 2002-05-17 2003-05-15 新規なペプチド組成物及び特にｃ型肝炎ウイルスに対して有効な医薬組成物の製造におけるその使用 Expired - Fee Related JP4309837B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0206111A FR2839722A1 (fr) 2002-05-17 2002-05-17 Nouvelles compositions peptidiques et leur utilisation notamment dans la preparation de compositions pharmaceutiques actives contre le virus de l'hepatite c
PCT/FR2003/001478 WO2003097677A2 (fr) 2002-05-17 2003-05-15 Nouvelles compostions peptidiques et leur utilisation notamment dans la preparation de compositions pharmaceutiques actives contre le virus de l'hepatite c

Publications (3)

Publication Number Publication Date
JP2006511442A JP2006511442A (ja) 2006-04-06
JP2006511442A5 true JP2006511442A5 (enExample) 2006-05-25
JP4309837B2 JP4309837B2 (ja) 2009-08-05

Family

ID=29286584

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004506350A Expired - Fee Related JP4309837B2 (ja) 2002-05-17 2003-05-15 新規なペプチド組成物及び特にｃ型肝炎ウイルスに対して有効な医薬組成物の製造におけるその使用

Country Status (12)

Country Link
US (5) US7393831B2 (enExample)
EP (1) EP1506225B2 (enExample)
JP (1) JP4309837B2 (enExample)
CN (1) CN1653086B (enExample)
AT (1) ATE332921T1 (enExample)
AU (1) AU2003255577A1 (enExample)
DE (1) DE60306771T3 (enExample)
DK (1) DK1506225T4 (enExample)
ES (1) ES2268411T5 (enExample)
FR (1) FR2839722A1 (enExample)
PT (1) PT1506225E (enExample)
WO (1) WO2003097677A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2839722A1 (fr) 2002-05-17 2003-11-21 Bio Merieux Nouvelles compositions peptidiques et leur utilisation notamment dans la preparation de compositions pharmaceutiques actives contre le virus de l'hepatite c
FR2855758B1 (fr) * 2003-06-05 2005-07-22 Biomerieux Sa Composition comprenant la polyproteine ns3/ns4 et le polypeptide ns5b du vhc, vecteurs d'expression incluant les sequences nucleiques correspondantes et leur utilisation en therapeutique
FR2862648B1 (fr) * 2003-11-21 2006-02-03 Biomerieux Sa Nouveau peptide immunogene et nouveaux epitopes et utilisations notamment dans la preparation de compositions pharmaceutiques actives contre le virus de l 'hepatite c
US20080249283A1 (en) * 2004-04-30 2008-10-09 Tomoya Miyakawa Hla-Binding Peptides, Precursors Thereof, Dna Fragments and Recombinant Vectors that Code for Those Peptide Sequences
MX2008011361A (es) * 2006-03-09 2008-09-15 Transgene Sa Proteina de fusion no-estructural del virus de hepatitis c.
JP5031827B2 (ja) 2006-06-01 2012-09-26 程云 予防或いは肝損傷を治療するペプチッド
EP2646459B1 (en) 2010-12-02 2020-01-08 Bionor Immuno AS Peptide scaffold design

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US132321A (en) * 1872-10-15 Improvement in platform-scales
US4007844A (en) * 1976-02-02 1977-02-15 Maxon Industries, Inc. Self folding platform
US4087007A (en) * 1976-12-01 1978-05-02 Leyman Manufacturing Co. Cargo platform system
US4198188A (en) * 1977-04-07 1980-04-15 Perkins William V Load elevator mechanism for unstable loads
US4563121A (en) * 1983-02-22 1986-01-07 Leyman Manufacturing Corp. Cargo elevator system
US4576541A (en) * 1984-02-29 1986-03-18 Leyman Manufacturing Corp. Safety latch for a cargo platform
US4627784A (en) * 1986-01-21 1986-12-09 Venco Manufacturing, Inc. Loading and unloading apparatus for a vehicle
US4725185A (en) * 1986-05-12 1988-02-16 Maxon Industries, Inc. Fail safe brake for rail type lifts
US4806062A (en) * 1987-10-29 1989-02-21 Maxon Industries, Inc. Stowable lift for freight vehicles
US5683864A (en) * 1987-11-18 1997-11-04 Chiron Corporation Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
US4930969A (en) * 1988-08-11 1990-06-05 Langer Hartford P Rail lift gate apparatus and storage scheme
KR0185373B1 (ko) 1989-03-17 1999-05-01 로버트 피. 블랙버언 Hcv 폴리단백질에서 유래되는 hcv 아미노산 서열 부분을 포함하는 폴리펩티드 및 그 사용
US5106726A (en) * 1990-02-16 1992-04-21 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV
US5747239A (en) * 1990-02-16 1998-05-05 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and preventions thereof as vaccines
US5639594A (en) * 1990-02-16 1997-06-17 United Biomedical, Inc. Linear and branched peptides effective in diagnosing and detecting non-A, non-B hepatitis
KR940000755B1 (ko) * 1990-02-16 1994-01-29 유나이티드 바이오메디칼 인코오포레이티드 Hcv에 대한 항체 검출, hcv 감염의 진단 및 백신으로서의 그 예방에 특히 적합한 합성 펩티드
US5582968A (en) * 1990-02-16 1996-12-10 United Biomedical, Inc. Branched hybrid and cluster peptides effective in diagnosing and detecting non-A, non-B hepatitis
HU217025B (hu) * 1990-04-04 1999-11-29 Chiron Corp. Hepatitis C vírus-(HCV) antigénkészítmények az anti-HCV-antitestek kimutatására immunoassay-kben
US5712087A (en) * 1990-04-04 1998-01-27 Chiron Corporation Immunoassays for anti-HCV antibodies employing combinations of hepatitis C virus (HCV) antigens
US5157504A (en) 1990-04-20 1992-10-20 Fuji Photo Film Co., Ltd. Copy cassette supplying apparatus
CA2047792C (en) * 1990-07-26 2002-07-02 Chang Y. Wang Synthetic peptides specific for the detection of antibodies to hcv, diagnosis of hcv infection and prevention thereof as vaccines
US5122026A (en) * 1990-09-17 1992-06-16 Leyman Manufacturing Corp. Cargo platform with plural storage positions
US6274148B1 (en) * 1990-11-08 2001-08-14 Chiron Corporation Hepatitis C virus asialoglycoproteins
ES2188583T3 (es) * 1991-06-24 2003-07-01 Chiron Corp Polipeptidos para el virus de la hepatitis c (hcv).
US5263808A (en) * 1991-11-27 1993-11-23 Leyman Manufacturing Corp. Automatic storage latch system for a cargo platform
BR9406652A (pt) 1993-03-05 1996-09-10 Cytel Corp Composição
US5709995A (en) * 1994-03-17 1998-01-20 The Scripps Research Institute Hepatitis C virus-derived peptides capable of inducing cytotoxic T lymphocyte responses
US5513943A (en) * 1994-05-16 1996-05-07 Tatcom, Inc. Load elevator with columnar power assemblies
US20030095980A1 (en) * 1994-07-29 2003-05-22 Geert Maertens Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
GB2294690B (en) * 1994-11-01 1998-10-28 United Biomedical Inc Peptides effective for diagnosis and detection of hepatitis C infection
US5597282A (en) * 1995-08-29 1997-01-28 Leyman Manufacturing Corporation Method and apparatus for unstacking and unloading a stacked load from one level to another level
US6534482B1 (en) * 1998-05-13 2003-03-18 Epimmune, Inc. Expression vectors for stimulating an immune response and methods of using the same
ES2371432T3 (es) * 1998-05-13 2012-01-02 Epimmune Inc. Vectores de expresión para estimular una respuesta inmune y procedimientos de uso de los mismos.
US7108855B2 (en) * 1998-06-24 2006-09-19 Innogenetics N.V. Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
AU765940B2 (en) * 1998-06-24 2003-10-02 Innogenetics N.V. Particles of HCV envelope proteins: use for vaccination
WO2001021189A1 (en) * 1999-07-19 2001-03-29 Epimmune Inc. Inducing cellular immune responses to hepatitis c virus using peptide and nucleic acid compositions
AU1236801A (en) * 1999-10-27 2001-05-08 Chiron Corporation Activation of hcv-specific t cells
FR2809402A1 (fr) * 2000-05-26 2001-11-30 Dev Des Antigenes Combinatoire Bibliotheques peptidiques combinatoires convergentes et leur application a la vaccination contre le virus de l'hepatite c
AUPQ776100A0 (en) * 2000-05-26 2000-06-15 Australian National University, The Synthetic molecules and uses therefor
AU2002219711B8 (en) 2000-12-08 2006-03-02 Academisch Ziekenhuis Leiden Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
DE10131978A1 (de) * 2001-07-02 2003-01-30 Witte Velbert Gmbh & Co Kg Drehfallenverschluss
FR2839722A1 (fr) 2002-05-17 2003-11-21 Bio Merieux Nouvelles compositions peptidiques et leur utilisation notamment dans la preparation de compositions pharmaceutiques actives contre le virus de l'hepatite c
US7695960B2 (en) * 2003-06-05 2010-04-13 Transgene S.A. Composition comprising the polyprotein NS3/NS4 and the polypeptide NS5B of HCV, expression vectors including the corresponding nucleic sequences and their therapeutic use
US7172689B2 (en) * 2004-02-20 2007-02-06 Bratten Jack R Arrangement and method for maintaining a minimum flow velocity in the coolant return of a machine tool coolant filtration system
US7491026B2 (en) * 2005-03-17 2009-02-17 Saf-Holland, Inc. Lift gate assembly
US7484921B2 (en) * 2005-08-24 2009-02-03 Murphy Michael O Lift gate system

Similar Documents

Publication Publication Date Title
Levey et al. Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease
WO2005010032A3 (en) Replikin peptides and uses thereof
JP2004521666A5 (enExample)
JP2005509846A5 (enExample)
EP2949658A3 (en) Peptides that specifically bind HGF receptor (cMet) and uses thereof
JP2005526147A5 (enExample)
JP2005526058A5 (enExample)
JP2006511442A5 (enExample)
WO2006010057A3 (en) Therapeutic peptides
JP2006512466A5 (enExample)
JP2005513162A5 (enExample)
JP2010501017A5 (enExample)
JP2005536763A5 (enExample)
NO20022147L (no) Mimetiske peptider for epitope av apolipoprotein B-100, konkatamer og modifiserte peptider derav, og vaksinesammensetningsom omfatter det samme
JP2005005118A5 (enExample)
JP2004526429A5 (enExample)
AU2003303889A1 (en) Polypeptides f' of the hepatitis c virus, epitopes, and the diagnostic and therapeutic applications thereof
JPH10273446A5 (enExample)
JP2002371226A5 (enExample)
徐晓东 John Donne and Metaphysical Tradition
JP2006515669A5 (enExample)
George Someone has to do it.
王国玲 The Lion and the Mouse
Edwards et al. Intel
RU2002107007A (ru) Туберкулостатическое средство